Rhodanine hydrolysis leads to potent thioenolate mediated metallo-β-lactamase inhibition

Rhodanine hydrolysis leads to potent thioenolate mediated metallo-β-lactamase inhibition
复制标题

DOI:
10.1038/nchem.2110
复制
发表时间:
2014-12-01
期刊:
影响因子:
21.8
通讯作者:
Schofield, Christopher J.
Schofield, Christopher J.
中科院分区:
化学1区
文献类型:
--
作者:
Brem, Juergen;van Berkel, Sander S.;Schofield, Christopher J.

文献摘要

被引文献

相似文献

β-内酰胺抗生素的使用受到耐药性的影响,耐药性由属于金属(MBL)-和丝氨酸(SBL)-β-内酰胺酶亚家族的β-内酰胺酶提供。罗丹宁是抑制青霉素结合蛋白(PBP)、SBL和最近报道的MBL的极少数化合物类别之一。在这里,我们描述了晶体学分析的机制,抑制临床相关的Vim-2 MBL的绕丹宁,这表明绕丹宁环进行水解,得到一个硫代烯醇化物。发现硫代烯醇盐通过二锌螯合结合,模拟β-内酰胺水解中中间体的结合。Vim-2在完整的若丹宁存在下结晶导致观察到MBL、硫代烯醇化物片段和若丹宁的三元复合物。晶体学观察得到了动力学和生物物理研究的支持,包括F-19 NMR分析,其揭示了若丹宁衍生的硫代烯醇盐是一种有效的广谱MBL抑制剂,并且是开发新型临床有用的MBL抑制剂的先导结构。
The use of beta-lactam antibiotics is compromised by resistance, which is provided by beta-lactamases belonging to both metallo (MBL)- and serine (SBL)-beta-lactamase subfamilies. The rhodanines are one of very few compound classes that inhibit penicillin-binding proteins (PBPs), SBLs and, as recently reported, MBLs. Here, we describe crystallographic analyses of the mechanism of inhibition of the clinically relevant VIM-2 MBL by a rhodanine, which reveal that the rhodanine ring undergoes hydrolysis to give a thioenolate. The thioenolate is found to bind via di-zinc chelation, mimicking the binding of intermediates in beta-lactam hydrolysis. Crystallization of VIM-2 in the presence of the intact rhodanine led to observation of a ternary complex of MBL, a thioenolate fragment and rhodanine. The crystallographic observations are supported by kinetic and biophysical studies, including F-19 NMR analyses, which reveal the rhodanine-derived thioenolate to be a potent broad-spectrum MBL inhibitor and a lead structure for the development of new types of clinically useful MBL inhibitors.